Sort
21,453 grants matching “tuberculosis”
Remodeling of the M. tuberculosis cell wall by the host microenvironment
$90,000Jordi B Torrelles · Ohio State University · K99 · FY2008 · AI
Formation and function of lamellipodial morphology in 3D microenvironments
$90,000Meghan Katrien Driscoll · Ut Southwestern Medical Center · K99 · FY2018 · GM
Formation and function of lamellipodial morphology in 3D microenvironments
$90,000Meghan Katrien Driscoll · Ut Southwestern Medical Center · K99 · FY2019 · GM
CD8 Tau cell contraction and memory formation
$90,000Martin Prlic · University Of Washington · K99 · FY2009 · AI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
$90,000Cory Michael Robinson · University Of Pittsburgh At Pittsburgh · K99 · FY2009 · HL
Controlling renal oxidative stress in CKD via targeting FGF23 bioactivity
$90,000Rafiou Agoro · Indiana University Indianapolis · K99 · FY2022 · DK
Transcriptional networks controlling molting in C. elegans and B. malayi
$89,996Jordan David Ward · University Of California, San Francisco · K99 · FY2014 · GM
Transcriptional networks controlling molting in C. elegans and B. malayi
$89,996Jordan David Ward · University Of California, San Francisco · K99 · FY2015 · GM
MEDICAL EDUCATION FOR TB CONTROL IN THE 21ST CENTURY
$89,932Harvard University (Medical School) · K07 · FY2000 · HL
MEDICAL EDUCATION FOR TB CONTROL IN THE 21ST CENTURY
$89,932Harvard University (Medical School) · K07 · FY2001 · HL
GEOGRAPHIC AND MOLECULAR CLUSTERING OF TUBERCULOSIS
$89,772Johns Hopkins University · R01 · FY2000 · AI
Transcriptional regulation of lipid homeostasis in mycobacteria
$89,732Hugo Gramajo · Institute Of Molecular /Cellular Biology · R01 · FY2014 · AI
Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients
$89,667Charissa Camille Naidoo · Stellenbosch University · K43 · FY2022 · TW
Research Program: Immunology and Vaccine Development
$89,613Philip D Greenberg · Fred Hutchinson Cancer Research Center · P30 · FY2015 · CA
Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients
$89,609Charissa Camille Naidoo · Stellenbosch University · K43 · FY2024 · TW
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES
$89,602California Pacific Med Ctr Res Institute · R01 · FY2002 · AI
Structures of RNA Processing and Silencing Enzymes in Prokaryotes
$89,580Hong Li · Florida State University · R01 · FY2017 · GM
The Role of ESCRT in Macrophage Resistance to Mycobacteria
$89,549Jennifer A Philips · New York University School Of Medicine · R01 · FY2014 · AI
CRAC Channel Deficiency in Immunity to Infection
$89,528Stefan Feske · New York University School Of Medicine · R01 · FY2014 · AI
Role of Chemokines in Anthrax Pathogenesis
$89,500J. David Gladstone Institutes · R03 · FY2004 · AI
Role of Chemokines in Anthrax Pathogenesis
$89,500J. David Gladstone Institutes · R03 · FY2003 · AI
Humoral immunity against the M. tuberculosis kasB persistent mutant
$89,420John R. Chan · Albert Einstein College Of Medicine, Inc · R21 · FY2018 · AI
Fatty Acid Analogs to treat Cancer/Infectious Diseases
$89,353University Of Puerto Rico Rio Piedras · S06 · FY2005 · GM
Developmental Core
$89,282John Koethe · Vanderbilt University Medical Center · P30 · FY2019 · AI
Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients
$89,253Charissa Camille Naidoo · Stellenbosch University · K43 · FY2025 · TW